Global Anti-Nuclear Antibody Test Market is Growing at a Significant Rate in the Forecast Period 2018-2025
Global Anti-Nuclear Antibody Test Market According to Data Bridge Market Research new Market report, “By Product Type (Assay Kits, Reagents, Systems, Software), By Test (Indirect Immunofluorescence, ELISA, Multiplex Testing), By Disease (Systemic Lupus Erythematosus, Sjögren’s Syndrome, Rheumatoid Arthritis, Scleroderma, Polymyositis, Others), By End User (Hospitals, Clinics, Physician Office Laboratories, Others), By Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast is projected to reach USD 2053.98 million by 2025, at a CAGR of 8.2% during the forecast period of 2018 to 2025.
Global Anti-Nuclear Antibody Test Market
Autoimmune disease is a condition in which the immune system attacks the body. The major role of the immune system is to guard us against foreign invaders like germs and bacteria. In normal conditions the immune system can differentiate between normal cells and foreign cells but in case of autoimmune disease, it releases proteins called antibodies that attack the healthy cells. Some of the most common autoimmune diseases are: Rheumatoid arthritis, Type 1 diabetes, Systemic lupus erythematosus, Multiple sclerosis, Graves’ disease, Addison’s disease, inflammatory bowel disease, Sjögren’s syndrome, Myasthenia gravis, Celiac disease, Vasculitis.
According to the study published on health line, it was found that women are more exposed to autoimmune diseases, with a rating of about 2 to 1 as compared to men. It means 6.4% of women and 2.7% of men. It was also found that lupus affects the African-American and Hispanic people more. The two types of tests that are commonly performed to detect antinuclear antibody test are: Enzyme-linked immunosorbent assay and indirect fluorescent antibody. Around 95% of the antinuclear antibody tests are performed to detect lupus autoimmune disease. It was also observed that about 60% of positive results were shown for systemic sclerosis and 40% of positive results were shown for Sjögren’s syndrome.
Segmentation: Global Anti-Nuclear Antibody Test Market
The global market for anti-nuclear antibody test by the following sub-categories is presented
- By Product Type
- Assay Kits
- By Test
- Indirect Immunofluorescence
- Multiplex Testing
- By Disease
- Systemic Lupus Erythematosus
- Sjögren’s Syndrome
- Rheumatoid Arthritis
- By End User
- Physician Office Laboratories
- By Geography
- North America
- South America
- Middle East and Africa
FACTORS DRIVING GROWTH IN THE GLOBAL ANTI-NUCLEAR ANTIBODY TEST MARKET
The increasing prevalence of autoimmune diseases:
Auto immune disease can cause type 1 diabetes. According to world health organization the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014. According to American Autoimmune Related Disease Association in the year 2016 around 50 million people suffered from autoimmune diseases in the U.S., out of which 70% were women.
The workshop held on autoimmune disease by the European Parliament’s Committee on Environment, Public Health and Food Safety states that American Autoimmune Related Disease Association has classified more than 100 autoimmune diseases making it third most common type of disease in the United States. In fact auto immune diseases affect 5-10% of the total world population. Some of the autoimmune diseases are the top 10 leading causes of death among the women aged 65 and above.
Lupus is the most common autoimmune disease which affects heart, lungs, kidneys and brain. According to the lupus foundation of America around 5 million of people worldwide and 1.5 million Americans are suffering from lupus. According to the center for disease control and prevention there are 16,000 new cases of lupus every year in the U.S.
Making the reference to 80 illness, national institute of health in 2005 reported that in the U.S. the prevalence of auto immune disease is between 14.7 million to 23.5 million.
According to the national institute of diabetes and digestive and kidney diseases, Addison’s disease occurs when adrenal glands get damaged and cannot produce enough cortisol and aldosterone. Addison’s disease affects almost 110- 144 per 1 million peoples in develop countries.
According to an article published in national arthritis month, 350 million people worldwide suffer from arthritis out of which 40 million are form the U.S. Also, approximately 2.1 million Americans suffer from rheumatoid arthritis.
Rise in government healthcare protection and increasing healthcare expenditure worldwide:
American Autoimmune Related Diseases Association (AARDA) is trying to increase awareness regarding the autoimmune diseases. This is a non-profitable agency whose main aim is to bring national focus on autoimmunity. AARDA provides patients with information and referrals through its national toll number 1-800-598-4668.
World Lupus federation launched a rally for creating awareness regarding lupus to improve the quality of life for more than 5 million people around the world living with autoimmune diseases worldwide. The Lupus Foundation of America is working to establish a federation of around 200 lupus organizations all around the world.
The efforts of the government to create awareness regarding autoimmune disease in the world is on rise, thus, showing that autoimmune disease is going to be a serious concern in future providing this market a strong platform in the upcoming years.
Some of the major players in the antinuclear antibody test market are Abbott., Bio-Rad Laboratories, Inc, Erba Diagnostics, Trinity Biotech, Thermo Fisher Scientific Inc., Antibodies Inc., EUROIMMUN AG, Immuno Concepts, Inova Diagnostics, ZEUS Scientific, Inc, BD, Biocom Biotech, F. Hoffmann-La Roche Ltd, HUMAN, ELITechGroup, Randox Laboratories Ltd, Accuquik™ Test Kits, AESKU.GROUP GmbH & Co. KG, AMS Alliance, Diesse Diagnostica Senese Spa, Avioq, Inc, MERCODIA AB.
Browse Related Reports:
Global Blood Screening Market, By Technology (Nucleic Acid Amplification, (rPCR), ELISA, (CLIA, Fluorescence assay), Rapid Test, NGS, Western Blotting), Product (Instrument, Reagent & Kits, Software) & End User (Blood Bank, Hospital), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.
Europe Injectable Drug Delivery Market, Type (Injectable Drug Delivery Devices,Injectable Drug Delivery Formulation), Application (Hormonal Disorders, oncology, autoimmune diseases), Usage Pattern (Curative Care, Other Usage Pattern ), Mode Of Administration, End User (Hospitals And Clinics, Home Healthcare Settings, Research Laboratories, Pharmaceutical And Biotechnological Companies, Other End Users), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, Direct Tender, Online Pharmacy),By Country (Germany, France, U.K., Belgium, Switzerland, Italy, Spain, Russia, Turkey, Netherland and rest of Europe) – Industry Trends and Forecast to 2025.
Global Topical Use Acne Treatment Market, By Drug Class (Antibiotics, Anti-Inflammatory Drugs, Antimicrobial, Combination Medications, Hormonal Agents, Oral Retinoid, and Topical Retinoid), By Route Of Administration (Topical, and Oral), By Type (Prescription and OTC), By Geography (North America, Europe, Asia-Pacific, Europe, South America, Middle East and Africa) – Industry Trends and Forecast to 2024.
Global Infusion Pump Systems, Accessories and Software Market, By Type (Infusion Pump Systems, Infusion Pump Accessories, Infusion Pump Management Software, Application (General Infusion, Pain and Anesthesia Management, Insulin Infusion, Enteral Infusion, Chemotherapy), End-User, Geography – Trends and Forecast to 2024